Abstract
Accumulating evidence has indicated that chronic inflammation is associated with a variety of diseases, including cancer, heart attacks, Alzheimer’s and other diseases. In the cancer research field, the association of inflammatory infiltration with cancer has been known histologically for a long time. Recent studies have indicated that macrophages and other immune cells infiltrate cancer tissues, expressing cytokines, chemokines and growth factors, thereby constructing an inflammatory microenvironment. In such a microenvironment, nuclear factor (NF)-κB is activated, which contributes to the growth and survival of cancer cells. Moreover, it has also been shown that NF-κB activation is associated with the acquisition of stem cell properties by cancer cells. Using inflammation-associated gastric cancer model mice (Gan mice), we have shown that tumor necrosis factor (TNF)-α signaling is activated in the inflammatory microenvironment and plays a tumor-promoting role by inducing Noxo1 in tumor cells. Taken together, these results indicate that regulation of chronic inflammation in tumor tissues would be an effective preventive and/or therapeutic strategy against cancer development and malignant progression.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barbie DA, Tamayo P, Boehm JS et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108–112
Barker N, Huch M, Kujala P et al (2010) Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6:25–36
Bollrath J, Phesse TJ, von Burstin VA et al (2009) gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15:91–102
Cooks T, Pateras IS, Tarcic O et al (2013) Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell 23:634–646
Greten FR, Eckmann L, Greten TF et al (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285–296
Grivennikov S, Karin E, Terzic J et al (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15:103–113
Itadani H, Oshima H, Oshima M et al (2009) Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics 10:615
Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG, Coward JI, Schioppa T, Robinson SC, Gallagher WM et al (2012) A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res 72:66–75
Myant KB, Cammareri P, McGhee EJ et al (2013) ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 12:761–773
Nakanishi M, Montrose DC, Clark P et al (2008) Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res 68:3251–3259
Oshima H, Oshima M (2012) The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol 47:97–106
Oshima M, Oshima H, Kitagawa K et al (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A 92:4482–4486
Oshima M, Dinchuk JE, Kargman SL et al (1996) Suppression of intestinal polyposis in Apc Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803–809
Oshima M, Murai N, Kargman S et al (2001) Chemoprevention of intestinal polyposis in the Apc Δ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61:1733–1740
Oshima H, Oshima M, Inaba K et al (2004) Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 23:1669–1678
Oshima H, Matsunaga A, Fujimura T et al (2006) Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 131:1086–1095
Oshima H, Oguma K, Du YC et al (2009) Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models. Cancer Sci 100:1779–1785
Oshima H, Hioki K, Popivanova BK et al (2011a) Prostaglandin E2 signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology 140:596–607
Oshima H, Popivanova BK, Oguma K et al (2011b) Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis. Cancer Sci 102:713–719
Oshima H, Ishikawa T, Yoshida GJ et al (2013) TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells. Oncogene 33:3820–3829
Putoczki TL, Thiem S, Loving A et al (2013) Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell 24:257–271
Schwitalla S, Fingerle AA, Cammareri P et al (2013a) Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152:25–38
Schwitalla S, Ziegler PK, Horst D et al (2013b) Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell 23:93–106
Seno H, Oshima M, Ishikawa TO et al (2002) Cyclooxygenase 2- and prostaglandin E2 receptor EP2-dependent angiogenesis in Apc Δ716 mouse intestinal polyps. Cancer Res 62:506–511
Sonoshita M, Takaku K, Sasaki N et al (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc Δ716 knockout mice. Nat Med 7:1048–1051
Sonoshita M, Takaku K, Oshima M et al (2002) Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res 62:6846–6849
Thun MJ, Namboodiri MM, Calle EE et al (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322–1327
Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181–193
Wang D, Wang H, Shi Q et al (2004) Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ. Cancer Cell 6:285–295
Xia D, Wang D, Kim SH et al (2012) Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat Med 18:224–226
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Japan
About this chapter
Cite this chapter
Oshima, H., Oshima, M. (2015). PGE2-Associated Inflammation and Gastrointestinal Tumorigenesis. In: Seya, T., Matsumoto, M., Udaka, K., Sato, N. (eds) Inflammation and Immunity in Cancer. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55327-4_2
Download citation
DOI: https://doi.org/10.1007/978-4-431-55327-4_2
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55326-7
Online ISBN: 978-4-431-55327-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)